We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Kyndryl
KD
$2.8B
| $143K | ﹤0.01% |
17,231
+3,380
| +24% | +$35.2K |
|
1577
PG&E
PCG
$29.4B
| $142K | ﹤0.01% |
+11,376
| New | +$133K |
|
1578
Invesco
IVZ
$13.3B
| $141K | ﹤0.01% |
10,271
+9,244
| +900% | +$156K |
|
1579
Broadridge
BR
$19.1B
| $140K | ﹤0.01% |
969
+954
| +6,360% | +$155K |
|
1580
Repay Holdings
RPAY
$315M
| $140K | ﹤0.01% |
+19,790
| New | +$216K |
|
1581
SITE Centers
SITC
$153M
| $139K | ﹤0.01% |
16,656
-2,610
| -14% | -$27.3K |
|
1582
Cencora
COR
$60.8B
| $134K | ﹤0.01% |
984
-884
| -47% | -$127K |
|
1583
Edison International
EIX
$21.1B
| $133K | ﹤0.01% |
2,353
+1,456
| +162% | +$96.4K |
|
|
SEE
1584
DELISTED
Sealed Air
SEE
| $133K | ﹤0.01% |
2,986
-3,911
| -57% | -$215K |
|
1585
Willis Towers Watson
WTW
$29.1B
| $133K | ﹤0.01% |
664
-252
| -28% | -$52K |
|
1586
Bankunited
BKU
$3.17B
| $132K | ﹤0.01% |
3,858
-16,766
| -81% | -$627K |
|
1587
CVRx
CVRX
$80.5M
| $131K | ﹤0.01% |
+14,000
| New | +$111K |
|
1588
TaskUs
TASK
$748M
| $129K | ﹤0.01% |
8,000
-4,000
| -33% | -$70.6K |
|
1589
First Advantage
FA
$3.7B
| $128K | ﹤0.01% |
10,000
| – | – |
|
1590
McCormick & Company Non-Voting
MKC
$13.5B
| $125K | ﹤0.01% |
1,747
-266
| -13% | -$22.3K |
|
1591
Transmedics
TMDX
$3.04B
| $123K | ﹤0.01% |
2,939
-70,209
| -96% | -$3.05M |
|
1592
Monster Beverage
MNST
$87.3B
| $121K | ﹤0.01% |
5,564
-232
| -4% | -$5.34K |
|
1593
Rithm Capital
RITM
$5.29B
| $121K | ﹤0.01% |
16,500
| – | – |
|
1594
United Natural Foods
UNFI
$2.79B
| $121K | ﹤0.01% |
3,533
-2,216
| -39% | -$94.4K |
|
|
SWTX
1595
DELISTED
SpringWorks Therapeutics
SWTX
| $120K | ﹤0.01% |
4,200
-21
| -0.5% | -$602 |
|
1596
Norwegian Cruise Line
NCLH
$6.67B
| $119K | ﹤0.01% |
10,440
+5,297
| +103% | +$69.8K |
|
1597
Procore
PCOR
$7.9B
| $116K | ﹤0.01% |
2,346
-350
| -13% | -$18.8K |
|
1598
Zebra Technologies
ZBRA
$16.1B
| $116K | ﹤0.01% |
444
-6,809
| -94% | -$2.11M |
|
1599
ResMed
RMD
$32.9B
| $114K | ﹤0.01% |
522
+37
| +8% | +$8.42K |
|
|
DMRA
1600
Damora Therapeutics
DMRA
$1.51B
| $113K | ﹤0.01% |
2,400
+800
| +50% | +$40.6K |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.